Burcu Ceylan Cura Yayla
Biographic Data
| ID | 7063871 |
|---|---|
| NAME | Burcu Ceylan Cura Yayla |
| GIVEN NAMES | Burcu Ceylan Cura |
| FAMILY NAME | Yayla |
| SIGNATURE | YAYLA B C C |
| AFFILIATIONS | Ministry of Health |
| ORCID | 0000-0001-5153-2136 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Comparison of Carbapenem vs. Amikacin Antimicrobial Therapy for Pediatric Acute Pyelonephritis Caused by Extended-Spectrum Β-Lactamase-Positive Enterobacteriaceae
Objectives : Acute pyelonephritis (APN) caused by extended-spectrum β-lactamase (ESBL)-positive Enterobacteriaceae poses a growing therapeutic challenge in children, as carbapenems remain the mainstay of treatment even when susceptibility to alternative agents such as amikacin is demonstrated. However, the widespread and inappropriate use of carbapenems can lead to carbapenem resistance. The aim of this study was to compare the clinical efficacy …
No prominent works on this page.
Comparison of Carbapenem vs. Amikacin Antimicrobial Therapy for Pediatric Acute Pyelonephritis Caused by Extended-Spectrum Β-Lactamase-Positive Enterobacteriaceae
Objectives : Acute pyelonephritis (APN) caused by extended-spectrum β-lactamase (ESBL)-positive Enterobacteriaceae poses a growing therapeutic challenge in children, as carbapenems remain the mainstay of treatment even when susceptibility to alternative agents such as amikacin is demonstrated. However, the widespread and inappropriate use of carbapenems can lead to carbapenem resistance. The aim of this study was to compare the clinical efficacy …
Amikacin (1 work) · Antibiotics (1 work) · Antimicrobial (1 work) · Beta-lactamase (1 work) · Biology (1 work) · Carbapenem (1 work) · Carbapenem-resistant enterobacteriaceae (1 work) · Cephalosporin (1 work) · Enterobacteriaceae (1 work) · Escherichia coli (1 work)